Page last updated: 2024-08-23

valrubicin and Leukemia

valrubicin has been researched along with Leukemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Myers, CE; Ozols, RF; Young, RC1
Larsson, BS; Mårs, U; Masquelier, M; Pålsson, M; Peterson, CO; Vitols, S1
Chuang, LF; Chuang, RY; Israel, M; Kung, HF1
Blair, OC; Carbone, R; Gamba-Vitalo, C; Lane, PA; Sartorelli, AC; Tritton, TR1

Reviews

1 review(s) available for valrubicin and Leukemia

ArticleYear
The anthracycline antineoplastic drugs.
    The New England journal of medicine, 1981, Jul-16, Volume: 305, Issue:3

    Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Daunorubicin; Doxorubicin; Female; Glycosides; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Naphthacenes; Ovarian Neoplasms; Sarcoma

1981

Other Studies

3 other study(ies) available for valrubicin and Leukemia

ArticleYear
Low density lipoprotein as a carrier of cytostatics in cancer chemotherapy: study of stability of drug-carrier complexes in blood.
    Journal of drug targeting, 2000, Volume: 8, Issue:3

    Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Doxorubicin; Drug Carriers; Female; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lipoproteins, LDL; Male; Mice; Mice, Inbred BALB C; Middle Aged; Paclitaxel

2000
Activation of human leukemia protein kinase C by tumor promoters and its inhibition by N-trifluoroacetyladriamycin-14-valerate (AD 32).
    Biochemical pharmacology, 1992, Feb-18, Volume: 43, Issue:4

    Topics: Binding, Competitive; Cell Membrane; Doxorubicin; Drug Interactions; Enzyme Activation; Humans; Kinetics; Leukemia; Phorbol 12,13-Dibutyrate; Phosphorylation; Protein Binding; Protein Kinase C; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1992
Cytotoxicity and differentiating actions of adriamycin in WEHI-3B D+ leukemia cells.
    Leukemia, 1987, Volume: 1, Issue:3

    Topics: Cell Cycle; Cell Differentiation; Cell Membrane; Cell Survival; DNA; Doxorubicin; Humans; Leukemia; Receptors, Fc; Structure-Activity Relationship; Tumor Cells, Cultured

1987